Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925478 · ClinicalTrials.gov registry record · Early Phase 1
Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage
A Early Phase 1 study of Subarachnoid Hemorrhage, Aneurysmal, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT05925478 is a Early Phase 1 study of Subarachnoid Hemorrhage, Aneurysmal that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 2 participants, below the 163-participant average among 8 other Subarachnoid Hemorrhage, Aneurysmal trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05925478, a Early Phase 1 study of Subarachnoid Hemorrhage, Aneurysmal, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
Aneurysmal subarachnoid hemorrhage (aSAH) can cause a severe headache (HA) that is famously treatment-resistant. Current pain regimens are too reliant on opioids, which results in long-term opioid dependence and can obfuscate the neurological examination, which is critical to detect vasospasm and delayed cerebral ischemia. This study will gather the initial evidence of whether the pterygopalatine fossa (PPF) regional anesthesia nerve block can treat aSAH-related HA and reduce opioid consumption in patients with aSAH.
Conditions Studied
Interventions
- PROCEDURE Ptergyopalatine Fossa Block
- DRUG Bupivacaine 0.25% Injectable Solution
Study Locations (1)
Texas
- UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2024-08-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05925478
The ClinicalTrials.gov registry entry for NCT05925478 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 8 other Subarachnoid Hemorrhage, Aneurysmal trials with a reported enrollment target (99% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Subarachnoid Hemorrhage, Aneurysmal appearing as the primary indexed condition, and to 2 interventions - of which Ptergyopalatine Fossa Block is the first listed.
NCT05925478 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05925478 about?
NCT05925478 is a clinical study titled "Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage". Aneurysmal subarachnoid hemorrhage (aSAH) can cause a severe headache (HA) that is famously treatment-resistant. Current pain regimens are too reliant on opioids, which results in long-term opioid dependence and can obfuscate the neurological examination, which is critical to detect vasospasm and de...
What is the current status of trial NCT05925478?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2023-11-06. Estimated completion is 2024-08-20.
What conditions does trial NCT05925478 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage, Aneurysmal.
What interventions are being tested in trial NCT05925478?
The interventions under investigation include: Ptergyopalatine Fossa Block (PROCEDURE), Bupivacaine 0.25% Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05925478?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05925478 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage, Aneurysmal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nimodipine Variability in SAH
RECRUITING
-
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
RECRUITING · NA
-
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
RECRUITING · Phase 4
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
Effects of Head-of-Bed on Intracranial Pressure
RECRUITING · NA
-
Augmented Renal Clearance in Neurocritical Care
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.